Zacks Analyst Blog Highlights Pfizer, Charles Schwab, Vale, Citigroup and Palo Alto Networks


For immediate release

Chicago, IL – April 14, 2022 – announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include Pfizer Inc. PFE, Charles Schwab SCHW, Vale SA VALE, Citigroup Inc. C, and Palo Alto Networks, Inc. PANW.

Here are highlights from Wednesday’s analyst blog:

Best Stock Reports for Pfizer, Charles Schwab and Vale

Zacks Research Daily features top research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Pfizer Inc., Charles Schwab and Vale SA. These research reports have been handpicked from the approximately 70 reports published today by our team of analysts.

You can see all today’s research reports here >>>

Shares of Pfizer outperformed Zacks Large Cap Pharmaceuticals’ industry over the past year (+48.1% vs. +35.8%), with the company’s industry-leading Covid vaccines/treatments driving momentum. The vaccine combined with Pfizer’s promising oral antiviral pill for COVID-19, Paxlovid, is expected to generate combined sales of $54 billion in 2022.

Pfizer has a sustainable pipeline with several late-stage programs that can drive growth. However, currency headwinds and pricing pressure are the main revenue headwinds. Concerns remain about its long-term growth drivers beyond its COVID-related products due to competitive pressure.

(You can read the full research report on Pfizer here >>>)

Shares of Charles Schwab outperformed the Zacks Financial – Investment Banking sector over the past year (+21.0% vs -0.7%). The Zacks analyst believes the strategic acquisitions have strengthened Schwab’s position as a major brokerage player. The same will likely have an accretive effect on earnings. The commission-free trading offer has resulted in an increase in client assets and brokerage accounts, thereby improving trading revenue.

Schwab’s efficient capital deployments reflect a strong balance sheet position, through which it will increase shareholder value. However, despite expectations of some rate hikes, relatively low interest rates will likely continue to hurt margins in the near term. High operating expenses could hamper the growth of the company’s results to some extent.

(You can read the full research report on Charles Schwab here >>>)

Valley Shares have gained +22.9% over the past year versus +8.2% for the S&P 500 index on the mining giant’s exposure to favorable price prospects for iron ore, copper and nickel. The Zacks analyst believes the company should end this year with higher production capacity, after the ramp-up of tailings filtration plants at the Itabira and Brucutu sites and their respective additions in storage capacity residues.

Efforts to improve productivity, introduce better quality ores to the market and control costs will also boost its results. On the strength of its strong cash flow, Vale continues to reduce its debt level while continuing to invest in projects that will drive the company’s growth. Vale has signed an agreement to sell its coal business to focus on its core business and become a leading low-carbon mining company.

(You can read the full research report on Vale here >>>)

Other noteworthy reports we feature today include Citigroup Inc. and Palo Alto Networks, Inc..

Why haven’t you watched Zacks best action?

Our top 5 performing strategies swept away the S&P’s impressive +28.8% gain in 2021. Surprisingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections at no cost or obligation.

See Free Stocks >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit for more information on the performance figures displayed in this press release.

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know our top 10 picks for all of 2022?

From its creation in 2012 to 2021, the Zacks Top 10 Stocks portfolios gained an impressive +1,001.2% vs. +348.7% for the S&P 500. Now our research director has combed through 4,000 companies covered by the Zacks Ranking and selected the top 10 tickers to buy and keep. Don’t miss your chance to enter…because the sooner you do, the more chances you have of winning.

See actions now >>

Click to get this free report

Citigroup Inc. (C): Free Stock Analysis Report

Pfizer Inc. (PFE): Free Inventory Analysis Report

The Charles Schwab Corporation (SCHW): Free Stock Analysis Report

VALE SA (VALE): Free Stock Analysis Report

Palo Alto Networks, Inc. (PANW): Free Stock Analysis Report

To read this article on, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Comments are closed.